INTERNATIONAL SOCIETY OF BLOOD TRANSFUSION

35th International congress of the ISBT

 

2-6 June 2018 Toronto
Close
N. Poster
Poster title
Applicant name
Status
  P-014 HOW ETHNIC DONOR INFORMATION SUPPORTS REQUESTS FOR TRANSFUSION Benjamin Villaseran Received Received
  P-019 IMPROVEMENTS IN PERIOPERATIVE BLOOD MANAGEMENT FOR PATIENTS ELIGIBLE FOR ELECTRONIC CROSSMATCH Kerry OBrien Received Received
  P-033 INTERNATIONALLY STANDARDIZED CODING AND LABELING IN BLOOD TRANSFUSION 24 YEARS LATER Mónica Freire Received Received
  P-039 NHSBT SUPPLY OF RARE RED CELLS 2015-2017 REKHA ANAND Received Received
  P-047 USAGE OF O RHD NEGATIVE RED CELLS IN FINLAND Tiia Kivipuro Received Received
  P-051 IMPACT OF 7-DAY PLATELETS ON INVENTORY MANAGEMENT AT A PEDIATRIC INSTITUTION Alex Ryder Received Received
  P-053 CHALLENGES TO PROVIDING BLOOD TO ALLOIMMUNIZED AFRICAN AMERICAN PATIENTS Margaret Keller Received Received
  P-057 INNOVATION OF BLOOD TRANSPORTATION SYSTEM IN LUMAJANG BLOOD CENTER Halimi Maksum Received Received
  P-059 PATIENT BLOOD MANAGEMENT: ANALYZING THE UTILITY OF UTILIZATION METRICS James Kelley Received Received
  P-062 GRANULOCYTES APHERESIS TRANSFUSIONS: THE FRENCH BLOOD MANAGEMENT IN 2016-2017 Geneviève WOIMANT Received Received
  P-081 PROCESS IMPROVEMENT TO DECREASE BLOOD PRODUCT WASTAGE AND IMPROVE COLD CHAIN EFFICACY Ritchelle Tabao Received Received
  P-087 THE IMPACT OF ANALYTICAL VARIATION OF HEMOGLOBIN MEASUREMENT ON BLOOD DONORS HEMOGLOBIN AND DEFERRAL RATE Johanna CASTRÉN Received Received
  P-094 TYPING NON-CONFORMING SAMPLES DUE TO MISLABELING ERRORS FOR IMPROVED DETECTION OF WRONG BLOOD IN TUBE (WBIT) Ann Wilson Received Received
  P-095 FEEDBACK OF AN EXTERNAL PROFICIENCY TESTING SCHEME BY INTERLABORATORY COMPARISON FOR QUALITY CONTROL OF BLOOD PRODUCTS AT THE EFS Stéphane Bégué Received Received
  P-109 PREDICTING BLOOD DONATION INTENTION: THE IMPORTANCE OF FEAR Philippe Gilchrist Received Received
  P-114 PREVALENCE OF CARDIO-VASCULAR RISK FACTORS AMONG BLOOD DONORS IN FRANCE Anne-Marie Fillet Received Received
  P-119 AUSTRALIAN BLOOD DONORS AND NON-DONORS VIEWS ON NON-CASH INCENTIVES FOR BLOOD DONATION Nina Van Dyke Received Received
  P-134 PROBABILITY TO BE A BLOOD DONOR IN OSLO DEPENDING ON GEOGRAPHICAL FACTORS Lise Sofie H Nissen-Meyer Received Received
  P-135 YOUTHTUBE A CASE STUDY ON A BLOOD DONATION SHORT FILM COMPETITION A 2-YEAR REVIEW Irene van Schalkwyk Received Received
  P-138 VOLUNTARY NON-REMUNERATED BLOOD DONATION IN THE RUSSIAN FEDERATION Alexander Chechetkin Received Received
  P-154 FROM FIRST-TIME PLASMA DONOR TO ESTABLISHING A ROUTINE: HOW DO DONORS DECIDE HOW OFTEN THEY WOULD LIKE TO DONATE PLASMA? Nina Van Dyke Received Received
  P-196 CALCIUM IN DRINKING WATER EFFECT ON IRON STORES IN DANISH BLOOD DONORS: RESULTS FROM THE DANISH BLOOD DONOR STUDY (DBDS) Andreas Stribolt Rigas Received Received
  P-200 HAEMOGLOBIN REGENERATION IN A FRENCH POPULATION OF NEW DONORS Jean-Yves Py Received Received
  P-201 FRENCH ORGANISATION TO PREVENT DONATIONS FROM ANAEMIC DONORS IS QUITE EFFECTIVE Jean-Yves Py Received Received
  P-205 STANDING ENHANCES VASOVAGAL SYMPTOMS ELICITED BY STIMULI ASSOCIATED WITH BLOOD BUT NOT OTHER EMOTIONAL STRESSORS Philippe Gilchrist Received Received
  P-206 DOES ANTI-HYPERTENSIVE MEDICATION POSE A RISK FOR THE DONOR? Kathrine M Neuman Johnsen Received Received
  P-228 WHOLE BLOOD PROCESSING USING DINCH BASED BLOOD CONTAINERS Konstanze Aurich Received Received
  P-233 A FIRST AUSTRALIAN STUDY WITH A NATIONAL APPROACH TO SYSTEMATIC TESTING OF DONORS WHEN THEIR WHOLE BLOOD DONATIONS ARE REPEATEDLY DISCARDED DUE TO RED CELL PROCESSING ISSUES Phillip Mondy Received Received
  P-236 STUDY OF MAGNESIUM ADDITIVE EFFECT ON RBC UNITS IN COMPARISON WITH UNITS ENRICHED WITH GLUATHIONE Sima Zolfaghari Received Received
  P-244 EFFECT OF PRE-PROCESSING HOLDING TIME ON THE QUALITY OF PLASMA RECOVERED FROM LEUKOREDUCED WHOLE BLOOD DONATIONS William Sheffield Received Received
  P-246 RED BLOOD CELLS FOR INTRAUTERINE TRANSFUSION: MEETING THE NEED THROUGH PHENOTYPING AND ANTI-CMV ANTIBODY TESTING Robert Romans Received Received
  P-265 2, 3 DIPHOSPHOGLYCERATE CONTENT AND OXYGEN AFFINITY OF HEMANEXT RED BLOOD CELLS STORED UNDER OXYGEN REDUCED CONDITIONS Samuel Sowemimo-Coker Received Received
  P-271 TRANSFUSION OF FRESH AND DATE OF EXPIRY RED BLOOD CELLS IN A SHEEP MODEL - AGE DOES NOT MATTER Gabriela Simonova Received Received
  P-275 OXYGEN IN RED BLOOD CELL CONCENTRATES: INFLUENCE OF DONORS CHARACTERISTICS, LOCATION AND BLOOD PROCESSING Michel Prudent Received Received
  P-277 PROTHROMBIN KNOCKDOWN ABROGATES ANTI-HEMORRHAGIC PROPERTIES OF TRANSFUSABLE PLASMA IN A MOUSE MODEL OF COAGULOPATHY William Sheffield Received Received
  P-290 EXPERIENCE OF THE IMPLEMENTATION OF INTERCEPT AMOTOSALEN TREATMENT FOR PLATELETS Thibaut BOCQUET Received Received
  P-298 SWIRLING SCORE LOSS IN APHERESIS PLATELETS FOLLOWING THE IMPLEMENTATION OF INTERCEPT PATHOGEN INACTIVATION Thibaut BOCQUET Received Received
  P-320 RETENTION OF THROMBIN GENERATION ACTIVITY IN POOLED WHOLE BLOOD-DERIVED PLASMA AFTER AMOTOSALEN-UVA PATHOGEN INACTIVATION AND STORAGE IS INDEPENDENT OF ABO BLOOD GROUPS catherine RAVANAT Received Received
  P-331 THAWED PLATELETS AND THAWED PLASMA CAN BE STORED FOR 2 WEEKS AT 4 DEGREES CELSIUS, A POSSIBLE NEW ASSET TO THE TREATMENT OF MAJOR HAEMORRHAGE IN THE PREHOSPITAL SETTING Femke Noorman Received Received
  P-332 CRYOPRESERVED SHEEP PLATELETS ARE HEMOSTATICALLY FUNCTIONAL: A SUITABLE PRECLINICAL TRANSFUSION MODEL Gabriela Simonova Received Received
  P-345 HUMAN PLATELETS LABELED AT MULTIPLE BIOTIN DENSITIES: A PROMISING APPROACH FOR MONITORING IN VIVO PLATELET SURVIVAL IN CLINICAL TRIALS catherine RAVANAT Received Received
  P-347 COLD STORAGES PROVOKES BIOMECHANICAL CHANGES AND AGGREGATE FORMATION IN PLATELET CONCENTRATES Konstanze Aurich Received Received
  P-352 COMPARISION STUDY OF THE NEWLY LAUNCHED ROCHE ELECSYS INFECTIOUS DISEASE PARAMETERS ON COBAS E 801 IN BLOOD DONOR SCREENING Caroline Tinguely Received Received
  P-354 HEV RNA SCREENING OF BLOOD DONATIONS BY A COMMERCIAL TRANSCRIPTION-MEDIATED AMPLIFICATION ASSAY (TMA): LINEAR CORRELATION BETWEEN TMA VALUES AND HEV VIRAL LOAD Sílvia SAULEDA Received Received
  P-362 A SAFE SCREENING ALGORITHM FOR INDIVIDUAL NUCLEIC ACID TESTING (ID-NAT): 10 YEARS OF EXPERIENCE IN A LOW ENDEMIC COUNTRY Martin Stolz Received Received
  P-371 USE OF A NOVEL TECHNOLOGY TO EFFECTIVELY WASH THE SAMPLE PIPETTOR DURING AUTOMATED BLOOD SCREENING ON THE ALINITY S Lynn Martin Received Received
  P-372 INDUCTION HEATING: AN ADVANCED WASHING TECHNOLOGY TO PRESERVE SAMPLE INTEGRITY ON ALINITY S FOR TRANSFER TO NAT INSTRUMENTS Pathik Soni Received Received
  P-373 ABBOTT ALINITY S ASSAYS ROBUSTNESS TO BIOTIN INTERFERENCE Lynn Martin Received Received
  P-375 PERFORMANCE OF NEW ASSAYS FOR HTLV I/II, HBC AND CHAGAS ON THE FULLY AUTOMATED ABBOTT ALINITY S SYSTEM Ben Marchlewicz Received Received
  P-376 PERFORMANCE OF NEW ASSAYS FOR HBSAG, HCV, AND HIV AG/AB COMBO ON THE FULLY AUTOMATED ABBOTT ALINITY S SYSTEM Ben Marchlewicz Received Received
  P-404 HEPATITIS CORE ANTIBODY SCREEING IN BLOOD DONORS IN SAUDI ARABIA Omer Alsaweed Received Received
  P-411 BLOOD TRANSFUSION SAFETY AND ELIMINATION OF HEPATITIS C IN GEORGIA Evan Bloch Received Received
  aP-440 IS PARVOVIRUS B19 A CONCERN FOR BLOOD SAFETY IN AUSTRALIA? Helen Faddy Received Received
  P-440 INACTIVATION OF YELLOW FEVER VIRUS IN PLASMA AND IN PLATELET CONCENTRATES FOLLOWING TREATMENT WITH THE THERAFLEX PATHOGEN INACTIVATION (PI) TECHNOLOGIES Helen Faddy Received Received
  P-473 EDUCATING RARE DONORS WHY IS THIS IMPORTANT? Tanya Powley Received Received
  P-480 ABO AND RH PHENOTYPE FREQUENCIES IN DRUZE POPULATION IN NORTHERN ISRAEL Hanna Morani Received Received
  P-485 AN ANTIBODY AGAINST A NOVEL HIGH INCIDENCE ANTIGEN IN THE INDIAN BLOOD GROUP SYSTEM Henny Christine Received Received
  P-492 HEMOLYTIC TRANSFUSION REACTION DUE TO AN ANTI-H ANTIBODY IN A SICKLE CELL DISEASE PATIENT Elena Lazarova Received Received
  P-504 SOFTWARE ASSISTED ANTIBODY IDENTIFICATION - IH-ABID Paul Aerts Received Received
  P-508 INTRODUCTION OF AUTOMATED HIGH TITRE ANTI-A AND/OR ANTI-B SCREENING IN AUSTRALIAN BLOOD DONORS Tanya Powley Received Received
  P-520 EXPERIENCE IN THE IMPLEMENTATION OF TYPE AND SCREEN - ABBREVIATED CROSSMATCH PROCEDURE (TAS-CIS) - IN A BLOOD BANK OF A HOSPITALS EMERGENCY CENTER IN LIMA PERU Elizabeth CARRILLO Received Received
  P-525 NOVEL RECOMBINANT CD38 FOR USE IN PRETRANSFUSION DIAGNOSTICS Matteo Binda Received Received
  P-526 COMPLICATION IN BLOOD COMPATIBILITY TESTING WITH DARATUMUMAB TREATMENT IN MULTIPLE MYELOMA: A CASE REPORT ANURAG GUPTA Received Received
  P-529 TWO CASES OF CAUCASIAN BOMBAY AND THREE CASES OF PARA-BOMBAY PHENOTYPE REVEALED FIVE NOVEL FUT1 ALLELES Hein Hustinx Received Received
  P-553 GENOTYPING PANEL DESIGNED TO IDENTIFY BLOOD DONORS LACKING HIGH PREVALENCE RH ANTIGENS Margaret Keller Received Received
  P-556 RHD AND RHCE ALLELES IN BRAZILIAN SICKLE CELL DISEASE PATIENTS WITH UNEXPLAINED RH ANTIBODIES CARLA DINARDO Received Received
  P-577 ASSOCIATION BETWEEN ANTI-D IMMUNOGLOBULIN DEVELOPMENT IN IMMUNISED BLOOD DONORS AND THE RED BLOOD CELL PHENOTYPE Joanne Tan Received Received
  P-583 RHD TYPING AMBIGUITIES IN MERGING SEROLOGICAL AND MOLECULAR DATA THE DETERMINING CONTRIBUTION OF GENE SEQUENICING TOMMASO MANCUSO Received Received
  P-584 UTILITY OF RED BLOOD CELL GENOTYPING OF BLOOD DONORS Margaret Keller Received Received
  P-596 ANTIBODY FORMATION PREDICTION IN TRANSFUSION-DEPENDENT PATIENTS Joanne Tan Received Received
  P-625 DONOR ANTI-HNA-3A, ANTI-HLA CLASS-I AND ANTI-HLA CLASS-II ANTIBODIES INDUCE NEUTROPHIL- AND MONOCYTE-MEDIATED HLMVEC DAMAGE IN A TWO-INSULT IN VITRO MODEL John-Paul Tung Received Received
  P-663 CORRELATION BETWEEN CONVENTIONAL COAGULATION TESTS AND ROTEM IN CHILDREN UNDERGOING CRANIOSYNOSTOSIS SURGERY RANJAN JOSHI Received Received
  P-687 ERYTHROCYTAPHERESIS,USEFUL ADJUNCT THERAPY IN PATIENTS WITH SEVERE MALARIA.HOSPITAL-BASED BLOOD BANK EXPERIENCE M. Isabel GONZALEZ MEDINA Received Received
  P-695 IRONING OUT ANAEMIA IN PREGNANT WOMEN Kristy Evans Received Received
  P-697 FERRITIN SCREENING FOR PATIENT BLOOD MANAGEMENT IN PREGNANCY Philip Crispin Received Received
  P-708 PATIENT BLOOD MANAGEMENT STRATEGIES ASSOCIATED WITH REDUCED TRANSFUSION RATES IN ELECTIVE ORTHOPAEDIC SURGICAL PATIENTS Leanna Pickles Received Received
  P-711 AGE OF BLOOD DOES NOT IMPACT OF THE FREQUENCY OF BLOOD TRANSFUSION IN MYELODYSPLASTIC SYNDROME Philip Crispin Received Received
  P-719 FRESH FROZEN PLASMA STORAGE DURATION ASSOCIATED WITH SMALL INCREASED IN-HOPSITAL MORTALITY RISK John-Paul Tung Received Received
  P-758 ACUTE HAEMOLYTIC TRANSFUSION REACTION DUE TO ANTI-MT Vincent Claes Received Received
  P-770 HAEMOVIGIL, A NEW SYSTEM TO PREVENT WRONG BLOOD IN TUBE (WBIT) AND TRANSFUSION ERRORS DUE TO PATIENT MIS-IDENTIFICATION: ONE YEAR EXPERIENCE AT A TERTIARY HOSPITAL IN INDIA Gautam Wankhede Received Received
  P-772 TACO: HOW DO WE PROMOTE AWARENESS AND REPORTING? Linley Bielby Received Received
  P-797 BLOOD UTILIZATION AND IMPACT OF CHRONIC TRANSFUSION THERAPY (CTT) IN A LARGE COHORT OF BRAZILIAN SICKLE CELL DISEASE (SCD) PATIENTS shannon kelly Received Received
  P-814 RED BLOOD CELL TRANSFUSION ADEQUACY INDEX AS TOOL FOR IMPROVING PATIENT BLOOD MANAGEMENT PROGRAM. Gustavo Duarte Received Received
  P-829 THE EFFECT OF CD34-PRE-COUNT, GENDER, AGE AND TYPE OF COLLECTION PROCEDURE ON COLLECTION EFFICIENCY IN STEM CELL COLLECTION FOR MULTIPLE MYELOMA Francis Swaneveld Received Received
  P-832 THE IMPACT OF THE CRYOPRESERVED PERIOD OF CB UNITS IN THE CHOICE FOR CB TRANSPLANTATION: THE CLINICIANS WOULD PREFER CB UNITS WITH SHORTER CRYOPRESERVED PERIODS THAN LONGER CB UNITS? Hye Ryun Lee Received Received
  P-854 PERFORMANCE EVALUATION OF THE SPECTRA OPTIA APHERESIS SYSTEM MONONUCLEAR CELL COLLECTION FOR AUTOLOGOUS PERIPHERAL STEM CELL TRANSPLANTATION tamima jisr Received Received
Tel.: +34 91 736 2385
LOCAL TIME
Contact: Katarina Gluic
Hours: Mon-Thu 8:30-17:00 Fri 8:30-15:00
00:15
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments

 

35th International congress of the ISBT

 

2-6 June 2018 Toronto
FAQs
Virtual Poster Gallery
Search and consult posters online
in an exclusive section
for each poster
    ACTIVE FROM 02/06/2018 TO 02/06/2018
Poster
Gallery
Upload
Poster
Featured Poster
Vote poster
Poster Discussion
Forum
                  




PosterSessionOnline
Logo Draft
 
Logo Cert